Oculis Holding
OCS
12 hedge funds and large institutions have $59.4M invested in Oculis Holding in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.
63,019,033% more capital inflows, than outflows
Capital inflows: $7.56M | Capital outflows: $12
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
1.15% more ownership
Funds ownership: 7.22% → 8.37% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$2.97M |
| 2 |
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
+$2.23M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.43M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$361K |
| 5 |
XTX Topco
George Town,
Cayman Islands
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$12 |
OCS Hedge Fund Activity: Q4 2024 in Review
12 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in Oculis Holding (OCS) for Q4 2024, worth a combined $59.4M — up 61% from $36.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OCS positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Aberdeen Group, adding an estimated $2.97M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $12 sold.
- 12 institutional investors held Oculis Holding (OCS) as of Q4 2024, up from 10 in Q3 2024.
- Funds reported $59.4M of Oculis Holding stock for Q4 2024, up 61% quarter-over-quarter.
- 3 funds opened new Oculis Holding positions in Q4 2024 and 1 closed out, a net change of +2 holders.
- The largest Oculis Holding buyer in Q4 2024 was Aberdeen Group, an estimated $2.97M added.
- The largest Oculis Holding seller in Q4 2024 was JP Morgan Chase, an estimated $12 sold.
Based on aggregated 13F filings for Q4 2024.